Question

A 35-year-old with newly diagnosed HIV-negative status asks about HIV PrEP options. Which statement is correct?

Accepted Answer

Long-acting injectable cabotegravir every 2 months is an approved PrEP option

Answer

Only daily TDF/FTC is approved

Answer

PrEP is only for men who have sex with men

Answer

Oral PrEP is contraindicated in women

Answer

PrEP should not be offered unless multiple partners are disclosed

Practice question

A 35-year-old with newly diagnosed HIV-negative status asks about HIV PrEP options. Which statement is correct?